TRUP Trupanion, Inc.
XNAS
35.53
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
TRUP
$35.53
—
What changed
Recent filings, trades and movesKey stats
$35.53
- 52-Week Range
- $21.16 – $40.69
- YTD
- -4.48%
- IV Rank (30D)
- 14.93
- Straddle Price
- $4.35
- P/C Vol Ratio
- 0.40
- Market Cap
- $1.6B
- Open
- $36.54
- Day Range
- $34.51 – $36.92
- Volume
- 378,873
- Prev Close
- $36.75
Fair Value
MODEL: SHORT
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.90% |
| Beta vs SPY | 1.55 |
| Cost of Equity (CAPM) | 13.45% (VRP-adj) |
| WACC | 13.18% |
| Volatility Risk Premium | +43.7pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 11.5% |
| Rev. Growth (YoY, DCF input) | +7.1% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.07 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.1B |
| Return on Equity (TTM) | 5.7% |
| Book / Price | 25.4% |
| Gross Margin (TTM) | 16.6% |
| FCF Margin (TTM) | 5.4% |
| Debt / Equity | 0.24 |
| Quality Score | 2/6 — normal (10y DCF) |
| Market-Implied Growth | +15.4% (reverse-DCF on current price) |
| SMA 50 | $27.14 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $29.77 |
| Bollinger Width / SMA20 | 35.3% (drives anchor stability) |
| Net Debt | $-0.1B |
| Market Cap | $2B |
Peers used for multiples: CHWY, ELAN, FRPT, IDXX, MRK, PETS, ZTS
(filtered from 8 ETF-co-members; sector bias active)
60-Day Conviction
40%
20-Day Fair Value
≈ by Dec 8, 2026
$35.02
α -1.3%
rank 46%
conviction
79%
40-Day Fair Value
≈ by Jan 6, 2027
$35.08
α -1.2%
rank 46%
conviction
43%
60-Day Fair Value
≈ by Feb 4, 2027
$34.98
α -1.4%
rank 46%
conviction
40%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $24.14 | 22% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $19.17 | 7% | median 33.8× · 5 peers |
| Peer EV/EBITDA | $19.22 | 7% | median 18.1× · 6 peers |
| Peer P/B | $75.44 | 7% | median 8.1× · 7 peers |
| Peer P/S | $98.86 | 7% | median 2.7× · 7 peers |
| Market Anchor (SMA50) | $27.14 | 38% | stability 85% (BB-width) |
| Options Expected (B-L 30d) | $37.69 | 13% | 12 strikes · skew +0.66 |
As of 2026-11-09 · updated
Related
About
- Industry (SIC)
- HOSPITAL & MEDICAL SERVICE PLANS (6324) · industry map
- Exchange
- XNAS
- Market Cap
- $1.6B
- Employees
- 1,121
- List Date
- 2014-07-18
- CIK
- 0001371285
- Last Earnings
- Nov 5 after close · +5.8% vs ±12.9% expected
- Next Earnings
- ~Feb 11, 2027 (estimated)
- Headquarters
- Seattle, WA
- Homepage
- https://www.trupanion.com
Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue majorly from subscription fees related to the company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on b…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -1.96% | -26.33% | 29.37% | -11.57% | -1.58% | -14.01% | -4.35% |
| Feb | -14.54% | -6.84% | -2.93% | -2.37% | -26.43% | -16.51% | -11.60% |
| Mar | -25.12% | 1.04% | -25.94% | 1.21% | 15.03% | -4.12% | -6.32% |
| Apr | 3.47% | -29.89% | -17.17% | -17.85% | -1.05% | -5.70% | -11.37% |
| May | 10.35% | -2.21% | -39.53% | 28.09% | 29.50% | -10.32% | 2.65% |
| Jun | 31.24% | -7.61% | -12.65% | 4.59% | 18.45% | 11.28% | 7.55% |
| Jul | -1.60% | 3.31% | 47.68% | 29.26% | -12.37% | -6.95% | 9.89% |
| Aug | -19.73% | 9.75% | 1.50% | 30.69% | 0.32% | 16.97% | 6.58% |
| Sep | -16.97% | -11.35% | -4.15% | -3.25% | -4.25% | -16.21% | -9.36% |
| Oct | 28.50% | -14.80% | -26.03% | 32.99% | -7.94% | 27.13% | 6.64% |
| Nov | 18.01% | 7.20% | 25.71% | -2.29% | -11.00% | 15.43%* | 8.84% |
| Dec | 17.74% | -9.17% | 3.92% | -10.16% | 9.81% | -- | 2.43% |
| Total | 10.08% | -63.37% | -43.51% | 83.49% | -4.26% | -13.31% | -5.15% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $30.23
SMA 50: $27.25
SMA 200: $26.64
Current: $35.49
EMA 12: $32.33
EMA 26: $30.07
MACD: 2.2631 | Signal: 0.6643
BULLISH
ADX (14): 44.24
STRONG TREND
+DI: 41.33
−DI: 4.35
Momentum Oscillators
RSI (14): 75.66
OVERBOUGHT
Stoch %K: 81.99
Stoch %D: 89.62
Williams %R: -31.45
Volume & Volatility
BB Upper: $35.79
BB Lower: $24.67
NEUTRAL
OBV: -6,013,172
Vol SMA 20: 430,855
Vol ROC: 73.45%
ATR: $1.70
True Range: $2.41
HV 20: 46.2%
HV 30: 41.0%
HV 60: 46.5%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-11-08T00:00:00 – 2026-11-06T00:00:00
AI Analysis
Written before TRUP’s Nov 5 earnings report, so it doesn’t reflect the results.
LLM Stock Analysis Report
SYMBOL: TRUP CURRENT PRICE: $24.89
Executive Summary Overall Assessment: NEUTRAL (Confidence Level: 6/10) Key Drivers: * Technical indicators suggest a consolidating market with no clear trend direction. * Recent news sentiment is predominantly positive, indicating potential support for the stock. Primary Risks: * Uncertainty around earnings and guidance, which could impact volatility and price movement.
Technical Analysis
Trend Direction: NEUTRAL (Short-term: Consolidation, Medium-term: Sideways Trend) Support/Resistance Levels: * Upper Bollinger Band: $33.34 * Lower Bollinger Band: $24.57 Momentum Signals: * RSI: 34.69 (Neutral) * MACD: Bullish (Histogram: 0.13) * Bollinger Bands: Neutral
Volume Analysis: * Volume SMA 20: 429250.25 * On-Balance Volume (OBV): -8263150.22 * Volume Rate of Change: -31.43%
News & Sentiment Analysis
Recent Headlines Summary: Positive news headlines from Trupanion, including paid claims milestones and veterinary appreciation awards.
Sentiment Assessment: POSITIVE
Catalyst Identification: None significant in the near term.
Market Narrative: Recent positive news may have contributed to the stock's consolidation phase.
Risk & Volatility Assessment
Beta Interpretation: Low volatility - stock moves less than market (0.14 vs SPY).
Volatility Regime: Historical volatility levels are low, indicating a relatively stable environment.
Options Market Signals: * IV Rank: 22.6% (Low) * Current IV: 77.2% * Expected Move: $3.60 (35 DTE), 7-DTE: $1.65 * Volume Flow: Bullish (5 calls vs 1 puts) * Open Interest: 15 calls vs 1 puts
Downside Protection: Support levels: Lower Bollinger Band ($24.57) and the 20-SMA ($28.96).
Market Context & Positioning
Sector Performance: Neutral, with no significant sector correlations.
Institutional Activity: Institutional interest is moderate, as indicated by volume patterns.
Correlation Analysis: Correlation to SPY (R-squared interpretation) is relatively low at -0.04, suggesting a degree of independence.
Relative Valuation: The stock is trading within its established range, with no clear overbought or oversold conditions.
Key Levels & Action Items
Critical Price Levels: * Lower Bollinger Band: $24.57 * Upper Bollinger Band: $33.34 Breakout/Breakdown Levels: * Above the 20-SMA ($28.96) could trigger a short-term uptrend. Time-Sensitive Catalysts: None significant in the near term.
Risk Management: Stop-loss levels should be set around the Lower Bollinger Band ($24.57). Position sizing considerations should prioritize risk management, focusing on maintaining a balanced portfolio.
Generated
News
All TRUP news →
Record profit came with a warning on veterinary cost inflation.
Earnings History
18 of 23 under expected move
Avg Expected Move
16.53%
Avg Actual Move
10.62%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-02-10 | After-Close | 11.33% | 11.34% | 1.00x | Exceeded |
| 2021-04-29 | After-Close | 13.63% | 1.72% | 0.13x | Within |
| 2021-08-05 | After-Close | 12.05% | 12.66% | 1.05x | Exceeded |
| 2021-11-03 | After-Close | 18.01% | 11.91% | 0.66x | Within |
| 2022-02-16 | After-Close | 12.56% | 17.02% | 1.36x | Exceeded |
| 2022-04-28 | After-Close | 21.84% | 7.78% | 0.36x | Within |
| 2022-08-03 | After-Close | 16.62% | 4.32% | 0.26x | Within |
| 2022-11-03 | After-Close | 16.93% | 3.30% | 0.19x | Within |
| 2023-02-15 | After-Close | 11.36% | 4.91% | 0.43x | Within |
| 2023-05-04 | After-Close | 20.08% | 19.67% | 0.98x | Within |
| 2023-08-03 | After-Close | 24.28% | 6.02% | 0.25x | Within |
| 2023-11-02 | After-Close | 22.65% | 14.30% | 0.63x | Within |
| 2024-02-15 | After-Close | 19.84% | 35.15% | 1.77x | Exceeded |
| 2024-05-02 | After-Close | 19.81% | 16.53% | 0.83x | Within |
| 2024-08-08 | After-Close | 17.98% | 9.33% | 0.52x | Within |
| 2024-10-30 | After-Close | 16.78% | 0.62% | 0.04x | Within |
| 2025-05-01 | After-Close | 18.45% | 23.49% | 1.27x | Exceeded |
| 2025-08-07 | After-Close | 13.59% | 0.12% | 0.01x | Within |
| 2025-11-06 | After-Close | 14.67% | 8.34% | 0.57x | Within |
| 2026-02-12 | After-Close | 13.38% | 13.01% | 0.97x | Within |
| 2026-04-30 | After-Close | 15.63% | 1.42% | 0.09x | Within |
| 2026-08-05 | After-Close | 15.89% | 15.46% | 0.97x | Within |
| 2026-11-05 | After-Close | 12.89% | 5.85% | 0.45x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
TRUP Options Activity & IV Rank
TRUP IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 45.8%
7-DTE IV: 45.3%
Expected Move: $4.35
7-DTE Move: $2.25
Days to Exp: 39 (2026-12-18)
Options Flow · All expiries
Call Volume: 212
Put Volume: 85
P/C Volume: 0.401
BULLISH
Call OI: 3,617
Put OI: 656
P/C OI: 0.181
Total OI: 4,273
ATM Options Pricing
ATM Call: $2.58
ATM Put: $1.77
Call %: 7.2%
Put %: 5.0%
Chain Summary
Chain Volume: 297
Chain OI: 4,273
Last Updated: 11/9/2026
Spread Scanner
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Dealer Positioning
HIGH γ vs HISTORY
Estimated net dealer gamma is at the 98th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
98%
vs own history
GEX tilt
+0.98
OI-weighted, today
Vanna tilt
+0.27
δ-sensitivity to IV
Charm tilt
-0.35
δ-decay vs time
Charm tilt -0.35: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 7 ATM contracts, 2k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
No data
30 DTE / 10d
—
—
pts
EXTREME
No data
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Loading the implied volatility surface…
Volatility Smile
Loading the implied volatility smile…
IV Rank (7 DTE)2.1LowNov 9
IV Rank (30 DTE)14.9LowNov 9
Straddle Price (30 DTE)$4.35Nov 9
Beta Analysis
Risk Metrics
Beta: -0.0314
Alpha: 3.45%
Correlation: -0.0090
R-Squared: 0.0%
Stock Volatility: 47.9%
Market Volatility: 13.8%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Negative beta - stock moves opposite to market
Negative beta - stock moves opposite to market
Beta & Alpha Over Time
Notable investors who own TRUP
4 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Millennium Management Hedge fund Izzy Englander | $1.5M | #2725 of 3716 | +32.6% | 13F | |
| Renaissance Technologies Hedge fund Jim Simons | $1.2M | #2234 of 3138 | +21.5% | 13F | |
| Citadel Hedge fund Ken Griffin | $1.1M | #3588 of 6285 | -43.3% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $13K | #3900 of 4729 | -40.5% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
TRUP Institutional Ownership (13F)
Filings for 2026-06-30 · 79 already for 2026-09-30
? 13F Guide
Diluted shares outstanding: 43,655,204 (as of 2026-06-30)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
5 filers$3.90M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Citadel Advisors LLC Custodian | $1.46M | 37.58% | 2026-06-30 |
| 2 | Jane Street Group, LLC Custodian | $1.37M | 35.16% | 2026-06-30 |
| 3 | Susquehanna International Group, LLP Custodian | $517.69K | 13.29% | 2026-06-30 |
| 4 | IMC-Chicago, LLC Custodian | $481.22K | 12.35% | 2026-09-30 |
| 5 | Simplex Trading, LLC Custodian | $63.07K | 1.62% | 2026-09-30 |
5 filers$1.48M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $715.85K | 48.35% | 2026-06-30 |
| 2 | IMC-Chicago, LLC Custodian | $420.48K | 28.40% | 2026-09-30 |
| 3 | Citadel Advisors LLC Custodian | $252.65K | 17.07% | 2026-06-30 |
| 4 | GROUP ONE TRADING LLC Custodian | $89.17K | 6.02% | 2026-06-30 |
| 5 | Simplex Trading, LLC Custodian | $2.34K | 0.16% | 2026-09-30 |
TRUP Insider Trading (Form 4)
Latest: 2026-10-30Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-30 | John R Gallagher | Chief Operating Officer | Sell (S) | −431 | $29.12 | -$12.6K | EDGAR |
| 2026-10-13 | Margaret Tooth | CEO | Sell (S) | −1,000 | $25.84 | -$25.8K | EDGAR |
| 2026-09-30 | John R Gallagher | Chief Operating Officer | Sell (S) | −431 | $22.92 | -$9.9K | EDGAR |
| 2026-09-15 | Margaret Tooth | CEO | Sell (S) | −1,000 | $25.00 | -$25.0K | EDGAR |
| 2026-09-01 | John R Gallagher | Chief Operating Officer | Sell (S) | −3,604 | $29.70 | -$107.0K | EDGAR |
| 2026-08-26 | Bradley S Powell | Director | Exer (M) | +1,640 | — | EDGAR | |
| 2026-08-26 | Simon Wheeler | EVP, Trupanion International | Mixed Tax −1,085 · Exer +2,173 |
+1,088 | $31.77 | -$34.5K | EDGAR |
| 2026-08-26 | Darryl Rawlings | Director | Exer (M) | +313 | — | EDGAR | |
| 2026-08-26 | Fawwad Qureshi | Chief Financial Officer | Mixed Sell −6,111 · Tax −5,486 · Exer +13,746 |
+2,149 | $30.85 | -$357.7K | EDGAR |
| 2026-08-26 | John R Gallagher | Chief Operating Officer | Mixed Exer +6,794 · Tax −1,651 |
+5,143 | $31.77 | -$52.4K | EDGAR |
| 2026-08-26 | Steve Weinrauch | EVP, North Am & Vet Strategy | Mixed Exer +4,859 · Tax −1,181 |
+3,678 | $31.77 | -$37.5K | EDGAR |
| 2026-08-26 | Margaret Tooth | CEO | Mixed Exer +19,042 · Sell −491 · Tax −7,000 |
+11,551 | $31.77 | -$238.0K | EDGAR |
| 2026-08-26 | Asher Bearman | Chief Legal Officer | Mixed Exer +2,610 · Tax −841 |
+1,769 | $31.76 | -$26.7K | EDGAR |
| 2026-08-26 | Brenna McGibney | Chief Administration Officer | Mixed Exer +6,430 · Tax −3,438 |
+2,992 | $31.77 | -$109.2K | EDGAR |
| 2026-08-26 | Howard E Rubin | Director | Exer (M) | +420 | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
TRUP Insider Holdings
21 insiders · @ $35.49
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Darryl Rawlings | Director | 1,460,491 | $51.84M | -$46.42M | 225 | 2026-08-26 |
| 2 | Howard E Rubin | Director | 233,148 | $8.28M | -$14.84M | 65 | 2026-08-26 |
| 3 | Margaret Tooth | CEO | 184,952 | $6.56M | -$7.17M | 113 | 2026-10-13 |
| 4 | Murray B Low | Director | 154,534 | $5.49M | -$5.98M | 57 | 2026-01-12 |
| 5 | Steve Weinrauch | EVP, North Am & Vet Strategy | 81,440 | $2.89M | -$1.08M | 33 | 2026-08-26 |
| 6 | Asher Bearman | Chief Legal Officer | 72,432 | $2.57M | -$11.76M | 48 | 2026-08-26 |
| 7 | Emily Dreyer | Chief Revenue Officer | 35,627 | $1.26M | -$972.2K | 29 | 2026-03-06 |
| 8 | John R Gallagher | Chief Operating Officer | 32,880 | $1.17M | -$938.2K | 43 | 2026-10-30 |
| 9 | Simon Wheeler | EVP, Trupanion International | 24,889 | $883.4K | $0 | 29 | 2026-08-26 |
| 10 | Jacqueline L Davidson | Director | 16,564 | $587.9K | $25.4K | 31 | 2025-01-03 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
TRUP Board & Officers
As of SEC filings through Oct 30, 2026Directors 9
- Darryl Rawlings · since Jul 17, 2014
- Howard E Rubin · since Jul 17, 2014
- Murray B Low · since Jul 17, 2014
- Jacqueline L Davidson · since Sep 5, 2018
- Elizabeth McLaughlin · since Apr 21, 2023
- Paulette R. Dodson · since Apr 21, 2023
- Richard Enthoven · since Nov 7, 2023
- Margaret Tooth · listed since Aug 2024
- Bradley S Powell · since Oct 29, 2025
Officers 9
- Margaret Tooth · CEO · listed since Aug 2024
- Fawwad Qureshi · Chief Financial Officer · since Sep 25, 2023
- John R Gallagher · Chief Operating Officer · listed since Feb 2025
- Brenna McGibney · Chief Administration Officer · since Mar 2, 2023
- Emily Dreyer · Chief Revenue Officer · listed since Aug 2025
- Asher Bearman · Chief Legal Officer · listed since Feb 2026
- Katherine Seawell · Chief Marketing Officer · since Aug 3, 2026
- Simon Wheeler · EVP, Trupanion International · since Mar 2, 2023
- Steve Weinrauch · EVP, North Am & Vet Strategy · since Mar 2, 2023
Changes in the last 10 years (65)
| Aug 3, 2026 | Katherine Seawell became Chief Marketing Officer |
| Apr 22, 2026 | The company announced the departure of Max Broden from the board in an SEC filing |
| Feb 17, 2026 | Asher Bearman first listed as Chief Legal Officer in an SEC filing |
| Oct 29, 2025 | Bradley S Powell became a director |
| Aug 19, 2025 | Emily Dreyer listed as Chief Revenue Officer (previously SVP, Channel Growth) in SEC filings |
| Feb 27, 2025 | John R Gallagher listed as Chief Operating Officer (previously EVP, Global Support Services) in SEC filings |
| Aug 20, 2024 | Margaret Tooth listed as CEO (previously President) in SEC filings |
| Aug 20, 2024 | Margaret Tooth first listed as a director in an SEC filing |
| Apr 30, 2024 | The company announced the departure of Darryl Rawlings as CEO in an SEC filing |
| Apr 23, 2024 | Christopher J Kearns became Chief Legal Officer |
| Apr 2, 2024 | The company announced the departure of Zay Satchu from the board in an SEC filing |
| Apr 2, 2024 | The company announced the departure of Dan Levitan from the board in an SEC filing |
| Nov 7, 2023 | Richard Enthoven became a director |
| Sep 25, 2023 | Fawwad Qureshi became Chief Financial Officer |
| Jul 3, 2023 | Max Broden became a director |
| Jun 1, 2023 | Wei Li became Interim CFO |
| May 30, 2023 | John R Gallagher listed as EVP, Global Support Services (previously General Manager) in SEC filings |
| May 30, 2023 | Andrew D. Wolff reported in an SEC filing no longer being Chief Financial Officer |
| Apr 21, 2023 | Paulette R. Dodson became a director |
| Apr 21, 2023 | Elizabeth McLaughlin became a director |
| Mar 2, 2023 | Travis Worra became General Manager |
| Mar 2, 2023 | Steve Weinrauch became EVP, North Am & Vet Strategy |
| Mar 2, 2023 | Simon Wheeler became EVP, Trupanion International |
| Mar 2, 2023 | Melissa Joy Hewitt became General Manager |
| Mar 2, 2023 | Kalpesh Raval became General Manager |
| Mar 2, 2023 | John R Gallagher became General Manager |
| Mar 2, 2023 | Jason Wasdin became General Manager |
| Mar 2, 2023 | Emily Dreyer became SVP, Channel Growth |
| Mar 2, 2023 | Brenna McGibney became Chief Administration Officer |
| Feb 2, 2023 | Tricia Plouf listed as EVP, Pricing (previously Chief Operating Officer) in SEC filings |
| Nov 1, 2022 | The company announced the departure of Eric L Johnson from the board in an SEC filing |
| May 27, 2022 | Gavin Friedman listed as EVP, Legal and Regulatory (previously EVP, People and Legal) in SEC filings |
| Mar 1, 2022 | Tricia Plouf listed as Chief Operating Officer (previously Co-President) in SEC filings |
| Mar 1, 2022 | Asher Bearman reported in an SEC filing no longer being EVP, Business Development |
| Dec 2, 2021 | Tricia Plouf listed as Co-President (previously President and CFO) in SEC filings |
| Sep 24, 2021 | Andrew D. Wolff became Chief Financial Officer |
| Jul 30, 2021 | Zay Satchu became a director |
| Jun 21, 2021 | Robin A Ferracone reported in an SEC filing no longer being a director |
| Jun 21, 2021 | H Hays Lindsley reported in an SEC filing no longer being a director |
| May 5, 2021 | Gavin Friedman listed as EVP, People and Legal (previously Chief People Officer) in SEC filings |
| Apr 28, 2021 | Asher Bearman listed as EVP, Business Development (previously Chief Strategy Officer) in SEC filings |
| Feb 23, 2021 | Tricia Plouf listed as President and CFO (previously Chief Financial Officer) in SEC filings |
| Feb 23, 2021 | Darryl Rawlings listed as CEO (previously President and CEO) in SEC filings |
| Feb 18, 2021 | Margaret Tooth listed as President (previously Chief Revenue Officer) in SEC filings |
| Dec 4, 2020 | Eric L Johnson became a director |
| Jan 1, 2020 | Gavin Friedman became Chief People Officer |
| Nov 26, 2019 | Thomas J Houk reported in an SEC filing no longer being Chief Member Exper. Officer |
| Mar 22, 2019 | Margaret Tooth listed as Chief Revenue Officer (previously Chief Marketing Officer) in SEC filings |
| Feb 26, 2019 | Asher Bearman listed as Chief Strategy Officer (previously Chief Administrative Officer) in SEC filings |
| Feb 1, 2019 | Thomas J Houk became Chief Member Exper. Officer |
| Sep 5, 2018 | Jacqueline L Davidson became a director |
| Sep 5, 2018 | Dan Levitan no longer listed as a 10% owner in SEC filings |
| Nov 9, 2017 | Maveron LLC reported in an SEC filing no longer being a 10% owner |
| Nov 9, 2017 | Maveron III Entrepreneurs Fund, L.P. reported in an SEC filing no longer being a 10% owner |
| Nov 9, 2017 | Maveron General Partner III LLC reported in an SEC filing no longer being a 10% owner |
| Nov 9, 2017 | Maveron Equity Partners III, L.P. reported in an SEC filing no longer being a 10% owner |
| Nov 9, 2017 | MEP Associates III, L.P. reported in an SEC filing no longer being a 10% owner |
| May 9, 2017 | Maveron LLC first listed as a 10% owner in an SEC filing |
| May 9, 2017 | Maveron III Entrepreneurs Fund, L.P. first listed as a 10% owner in an SEC filing |
| May 9, 2017 | Maveron General Partner III LLC first listed as a 10% owner in an SEC filing |
| May 9, 2017 | Maveron Equity Partners III, L.P. first listed as a 10% owner in an SEC filing |
| May 9, 2017 | MEP Associates III, L.P. first listed as a 10% owner in an SEC filing |
| May 9, 2017 | Dan Levitan first listed as a director in an SEC filing |
| May 9, 2017 | Dan Levitan first listed as a 10% owner in an SEC filing |
| Feb 3, 2017 | Asher Bearman became Chief Administrative Officer |
Not reported recently (12)
- Jason Wasdin · Last reported as General Manager in an SEC filing dated Mar 3, 2025
- Melissa Joy Hewitt · Last reported as General Manager in an SEC filing dated Mar 3, 2025
- Christopher J Kearns · Last reported as Chief Legal Officer in an SEC filing dated Mar 3, 2025
- Travis Worra · Last reported as General Manager in an SEC filing dated Nov 27, 2024
- Kalpesh Raval · Last reported as General Manager in an SEC filing dated Nov 27, 2024
- Michael Doak · Last reported as a director in an SEC filing dated Sep 1, 2023
- Wei Li · Last reported as Interim CFO in an SEC filing dated Aug 29, 2023
- Tricia Plouf · Last reported as EVP, Pricing in an SEC filing dated Feb 10, 2023
- Gavin Friedman · Last reported as EVP, Legal and Regulatory in an SEC filing dated Feb 3, 2023
- Chad M Cohen · Last reported as a director in an SEC filing dated Apr 3, 2019
- Glenn W Novotny · Last reported as a director in an SEC filing dated Apr 3, 2018
- Ian Moffat · Last reported as Chief Operating Officer in an SEC filing dated Feb 22, 2018
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
TRUP Proposed Insider Sales (Form 144)
Latest: 2026-10-28
? Form 144 Guide
Last 30d:
2 filings
· $38K notice value
· Last 90d:
7 filings
· $392K notice value
· 3 unique filers
· 100% under 10b5-1 plans
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
Top 90-day filers:
FAWWAD QURESHI (1, $183K) · JOHN GALLAGHER (3, $129K) · MARGARET R TOOTH (3, $79K)
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-10-28 | JOHN GALLAGHER | Officer | 431 | $12.6K | 2026-10-28 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-10-09 | MARGARET R TOOTH | Officer, Director | 1,000 | $25.8K | 2026-10-09 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-09-28 | JOHN GALLAGHER | Officer | 431 | $9.9K | 2026-09-28 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-09-11 | MARGARET R TOOTH | Officer, Director | 1,000 | $25.0K | 2026-09-11 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-08-28 | JOHN GALLAGHER | Officer | 3,604 | $107.0K | 2026-08-28 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-08-26 | FAWWAD QURESHI | Officer | 6,111 | $183.4K | 2026-08-26 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-08-11 | MARGARET R TOOTH | Officer, Director | 978 | $28.4K | 2026-08-11 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-07-28 | JOHN GALLAGHER | Officer | 431 | $10.8K | 2026-07-28 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-06-29 | JOHN GALLAGHER | Officer | 431 | $10.9K | 2026-06-29 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-06-05 | STEVE A WEINRAUCH | Officer | 6,674 | $146.8K | 2026-06-05 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-11-05
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
| Filing Date | Accession | Link |
|---|
ETF Holders
79 ETFs hold TRUP
25 shown · $280.74M total exposure · 0.05% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | IJR iShares Core S&P Small-Cap ETF | iShares (BlackRock) | 0.08% | $82.9M | $103.8B | 2026-11-06 |
| 2 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.05% | $34.9M | $76.6B | 2026-11-06 |
| 3 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $24.3M | — | 2026-09-30 |
| 4 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.01% | $17.3M | — | 2026-09-30 |
| 5 | FESM Fidelity Enhanced Small Cap Core ETF | Fidelity | 0.21% | $14.1M | $6.6B | 2026-11-05 |
| 6 | AVUV Avantis U.S. Small Cap Value ETF | Avantis | 0.04% | $13.7M | $31.6B | 2026-11-05 |
| 7 | IWO iShares Russell 2000 Growth ETF | iShares (BlackRock) | 0.09% | $11.9M | $13.7B | 2026-11-06 |
| 8 | SPSM State Street® SPDR® Portfolio S&P 600™ Small Cap ETF | SPDR (State Street) | 0.07% | $11.8M | $15.7B | 2026-11-05 |
| 9 | VXF Vanguard Extended Market ETF | Vanguard | 0.01% | $9.9M | — | 2026-09-30 |
| 10 | VBK Vanguard Morningstar Small-Cap Growth ETF | Vanguard | 0.02% | $9.6M | — | 2026-09-30 |
| 11 | IJT iShares S&P Small-Cap 600 Growth ETF | iShares (BlackRock) | 0.11% | $8.1M | $7.3B | 2026-11-06 |
| 12 | SLYG State Street® SPDR® S&P 600™ Small Cap Growth ETF | SPDR (State Street) | 0.11% | $4.8M | $4.6B | 2026-11-05 |
| 13 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.02% | $4.7M | — | 2026-08-31 |
| 14 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.03% | $4.6M | — | 2026-09-30 |
| 15 | IJS iShares S&P Small-Cap 600 Value ETF | iShares (BlackRock) | 0.05% | $3.8M | $7.5B | 2026-11-06 |
| 16 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.01% | $3.6M | — | 2026-11-05 |
| 17 | VIOO Vanguard S&P Small-Cap 600 ETF | Vanguard | 0.05% | $3.1M | — | 2026-09-30 |
| 18 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.04% | $2.8M | — | 2026-11-05 |
| 19 | RWJ Invesco S&P SmallCap 600 Revenue ETF | Invesco | 0.13% | $2.7M | — | 2026-11-05 |
| 20 | SLYV State Street® SPDR® S&P 600™ Small Cap Value ETF | SPDR (State Street) | 0.05% | $2.4M | $4.9B | 2026-11-05 |
| 21 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.00% | $2.3M | — | 2026-11-05 |
| 22 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.00% | $2.1M | $93.2B | 2026-11-06 |
| 23 | PAWZ ProShares Pet Care ETF | ProShares | 5.56% | $1.9M | — | 2026-11-06 |
| 24 | AVSC Avantis U.S. Small Cap Equity ETF | Avantis | 0.06% | $1.8M | $3.2B | 2026-11-05 |
| 25 | VFH Vanguard Financials ETF | Vanguard | 0.01% | $1.3M | — | 2026-09-30 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
66.97
TTM Diluted EPS
$0.53
TTM Revenue
$1.52B
TTM Net Income
$23.21M
TTM Op. Cash Flow
$94.08M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $392.93M | $6.83M | $0.16 | $20.98M |
| Q1 '26 | 2026-03-31 | $384.05M | $4.88M | $0.11 | $14.59M |
| Q4 '25 | 2025-12-31 | $376.85M | $5.63M | $0.13 | $29.26M |
| Q3 '25 | 2025-09-30 | $366.92M | $5.87M | $0.13 | $29.24M |
| Q2 '25 | 2025-06-30 | $353.56M | $9.41M | $0.22 | $15.03M |
| Q1 '25 | 2025-03-31 | $341.98M | $-1.48M | $-0.03 | $15.96M |
| Q4 '24 | 2024-12-31 | $337.31M | $1.66M | $0.04 | $23.70M |
| Q3 '24 | 2024-09-30 | $327.46M | $1.43M | $0.03 | $15.29M |
| Q2 '24 | 2024-06-30 | $314.80M | $-5.86M | $-0.14 | $6.86M |
| Q1 '24 | 2024-03-31 | $306.12M | $-6.85M | $-0.16 | $2.43M |
| Q4 '23 | 2023-12-31 | $295.86M | $-2.16M | $-0.05 | $17.51M |
| Q3 '23 | 2023-09-30 | $285.85M | $-4.04M | $-0.10 | $11.40M |
Q2 2026 • period ending 2026-06-30 • filed 2026-08-05
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
66.97
P/B
3.78
P/S
1.02
EV/EBITDA
36.75
EV/Sales
0.98
ROE
5.7%
ROA
2.5%
Div Yield
0.00%
FCF Yield
6.07%
Debt/Equity
0.24
Current Ratio
—
Market Cap
$1.55B
as of 2026-11-09
TRUP vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| MRK Merck & Co., Inc. | $361.7B | 153.1 | +4.9% | +39.5% | 44 |
| IDXX Idexx Laboratories Inc | $53.3B | 47.7 | +11.9% | +5.6% | 20 |
| ZTS ZOETIS INC. | $32.3B | 13.6 | +2.6% | −34.7% | 9 |
| ELAN Elanco Animal Health Incorporated Common | $12.9B | — | +12.0% | +21.0% | 1 |
| CHWY Chewy, Inc. | $9.1B | 37.9 | +6.1% | −32.0% | 83 |
| FRPT Freshpet, Inc. | $3.1B | 17.7 | +12.8% | +12.1% | 18 |
| TRUP Trupanion, Inc. | $1.6B | 67.0 | +11.8% | −4.6% | 15 |
| PETS PetMed Express, Inc. | $26M | — | −21.1% | −62.0% | — |
| VIRP VIRP | — | — | — | — | — |
| Peer median | $12.9B | 37.9 | +6.1% | +5.6% | 19 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
3.68M
SI % of Float
10.95%
Days to Cover
9.31
Short Vol Ratio
70.6%
Free Float
33.57M
Float %
76.5%
Short interest 2026-10-15 • Short volume 2026-11-06 • Float 2026-08-24